Litcius/Paper detail

Sacubitril, valsartan and SARS-CoV-2

Antonio Vitiello, Raffaele La Porta, Francesco Ferrara

2020BMJ evidence-based medicine31 citationsDOIOpen Access PDF

Abstract

<h3>Abstract</h3> Poorly controlled glucose levels are associated with serious morbidity and mortality in hospitalized patients. Hospital diabetes management aims to maintain the glucose level within a desired range, primarily via insulin administration. Current inpatient glucose control relies significantly on expert knowledge, but this results in large variability and often suboptimal blood sugars in practice. We applied supervised machine learning methods to electronic health record (EHR) data to build predictive models that can inform inpatient insulin management. We found that individual blood glucose levels and insulin dosing are highly erratic and cannot be predicted precisely (MAE 28mg/dL, R<sup>2</sup> 0.2). However, prescribing decisions can still be driven by the more reliable predictions of average daily glucose levels (MAE 21mg/dL, R<sup>2</sup> 0.4) and whether any patient’s glucose levels will be higher than the clinically desired range in the next day (sens 0.73, spec 0.79).

Topics & Concepts

DosingValsartanInsulinMedicineDiabetes mellitusPlasma glucoseEmergency medicineCoronavirus disease 2019 (COVID-19)Continuous glucose monitoringIntensive care medicinePharmacologyType 1 diabetesInternal medicineEndocrinologyBlood pressureDiseaseInfectious disease (medical specialty)Hyperglycemia and glycemic control in critically ill and hospitalized patientsSepsis Diagnosis and TreatmentDiabetes Management and Research